hydroxychloroquine has been researched along with HIV in 5 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The rapid spread of the new Coronavirus Disease 2019 (COVID-19) has actually become the newest challenge for the healthcare system since, to date, there is not an effective treatment." | 2.66 | Recent Clinical and Preclinical Studies of Hydroxychloroquine on RNA Viruses and Chronic Diseases: A Systematic Review. ( De Tommasi, N; Faraone, I; Labanca, F; Milella, L; Ponticelli, M, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brest, P | 1 |
| Benzaquen, J | 1 |
| Klionsky, DJ | 1 |
| Hofman, P | 1 |
| Mograbi, B | 1 |
| Rivas, N | 1 |
| Espinoza, M | 1 |
| Loban, A | 1 |
| Luque, O | 1 |
| Jurado, J | 1 |
| Henry-Hurtado, N | 1 |
| Goodridge, A | 1 |
| Faraone, I | 1 |
| Labanca, F | 1 |
| Ponticelli, M | 1 |
| De Tommasi, N | 1 |
| Milella, L | 1 |
| Cui, X | 1 |
| Sun, J | 1 |
| Minkove, SJ | 1 |
| Li, Y | 1 |
| Cooper, D | 1 |
| Couse, Z | 1 |
| Eichacker, PQ | 1 |
| Torabi-Parizi, P | 1 |
| Chazerain, P | 1 |
| Palazzo, E | 1 |
| Bouscarat, F | 1 |
| Grossin, M | 1 |
| Picard, C | 1 |
| Meyer, O | 1 |
| Belaich, S | 1 |
| Kahn, MF | 1 |
3 reviews available for hydroxychloroquine and HIV
| Article | Year |
|---|---|
Recent Clinical and Preclinical Studies of Hydroxychloroquine on RNA Viruses and Chronic Diseases: A Systematic Review.
Topics: Arthritis, Rheumatoid; Betacoronavirus; Chikungunya Fever; Chikungunya virus; Coronavirus Infections | 2020 |
Effects of chloroquine or hydroxychloroquine treatment on non-SARS-CoV2 viral infections: A systematic review of clinical studies.
Topics: Alphapapillomavirus; Antiviral Agents; Chikungunya Fever; Chikungunya virus; Chloroquine; COVID-19; | 2021 |
Polyarthritis with cutaneous mucinosis and intrasynovial mucin deposits.
Topics: Adult; Antirheumatic Agents; Arthritis; Follow-Up Studies; HIV; HIV Seropositivity; Humans; Hydroxyc | 1997 |
2 other studies available for hydroxychloroquine and HIV
| Article | Year |
|---|---|
Open questions for harnessing autophagy-modulating drugs in the SARS-CoV-2 war: hope or hype?
Topics: Anti-Inflammatory Agents; Antiviral Agents; Autophagy; Chloroquine; COVID-19; COVID-19 Drug Treatmen | 2020 |
Case Report: COVID-19 Recovery from Triple Infection with
Topics: Adult; Antitubercular Agents; Antiviral Agents; Betacoronavirus; Coinfection; Convalescence; Coronav | 2020 |